OTC serums often label 1% peptide blend, but actual GHK-Cu is a fraction of that
Individuals with metabolic imbalances, chronic inflammation, or slowed regenerative capacity that may limit response to peptide-based interventions
This podcast has become a powerful space where people living with obesity, GLP-1 medication users, clinicians, and advocates share their stories, expertise, and lived experience
Other GLP-1 receptor agonists have also been shown to be effective at treating both type 2 diabetes and obesity in children, leading to significant reductions in blood sugar levels, body weight, body mass index (BMI), and blood pressure
Intramuscular injection is unnecessary and offers no advantage for this peptide
Learn more: Wegovy plateau: Why weight loss stalls and what to do next Can stopping and restarting semaglutide affect results